Literature DB >> 15380939

Techniques: species' finest blend--humanized mouse models in inflammatory skin disease research.

Frederik H Igney1, Khusru Asadullah, Thomas M Zollner.   

Abstract

Differences between humans and mice often hamper the transfer of promising results from the bench to the clinic. For ethical reasons, research that involves patients is limited, and so there is an urgent need for models that mimic the human situation as closely as possible. In recent years, there has been considerable progress in generating humanized mouse models, and their application to drug discovery has proved fruitful. So, how can mice be humanized, and how can humanized mice be employed in immunology research and drug discovery? In this article, we answer these questions, focusing on T-cell-mediated skin diseases as an example.

Entities:  

Mesh:

Year:  2004        PMID: 15380939     DOI: 10.1016/j.tips.2004.08.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  3 in total

1.  Willingness to Donate Human Samples for Establishing a Dermatology Research Biobank: Results of a Survey.

Authors:  Durdana Gross; Arndt A Schmitz; Richardus Vonk; Frederik H Igney; Wolf-Dietrich Döcke; Stefanie Schoepe; Wolfram Sterry; Khusru Asadullah
Journal:  Biopreserv Biobank       Date:  2011-09       Impact factor: 2.300

Review 2.  Humanized mice for the study of type 1 diabetes and beta cell function.

Authors:  Marie King; Todd Pearson; Aldo A Rossini; Leonard D Shultz; Dale L Greiner
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

3.  Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.

Authors:  Vivian L de Oliveira; Romy R M C Keijsers; Peter C M van de Kerkhof; Marieke M B Seyger; Esther Fasse; Lars Svensson; Markus Latta; Hanne Norsgaard; Tord Labuda; Pieter Hupkens; Piet E J van Erp; Irma Joosten; Hans J P M Koenen
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.